Technology Solutions

Site-less, PI-less Trials?

Thursday, June 10, 2010

Quincy Bioscience just may be on to something. The Madison, Wis.-based maker of the jellyfish-based supplement Prevagen has just launched a portal that allows most interactions with its study subjects to take place exclusively online.

[Read More]

University of North Carolina, Olympus Open Advanced Imaging Center

Monday, June 7, 2010

The University of North Carolina at Chapel Hill has opened a new facility designed to be one of the world’s most sophisticated research centers devoted to life science imaging. The UNC-Olympus Research Imaging Center provides researchers with advanced equipment, software, consultation and expertise and is designed to stimulate collaboration among top life science research faculty members. It will be available to guest researchers as well.

[Read More]

Novotech Becomes Medidata Solutions’ Partner

Friday, June 4, 2010

Medidata Solutions, a global eClinical provider, announced that Australian contract research organization (CRO) Novotech has joined Medidata’s ASPire to Win channel partner program. As Australia’s largest full-service Australian CRO with extensive operations across Asia, Novotech can now offer sponsors a full range of services around the Medidata Rave electronic data capture (EDC) and clinical data management (CDM) solution.

[Read More]

Parexel Releases eClinical Platform for Late-Stage Clinical Trials

Tuesday, April 13, 2010

Parexel, a CRO, released a new web-based platform to be used in late-phase clinical research to help users meet regulatory guidelines and ensure high quality data. The new product combines the expertise of Parexel’s existing Peri Approval Clinical Excellence (PACE) team with the eClinical capabilities of Perceptive Informatics, Parexel’s technology subsidiary. The platform allows for a variety of eClinical services, such as clinical trial management systems, electronic data capture, randomization and trial supply management, and electronic patient-reported outcomes, to be incorporated in late-phase studies.

[Read More]